Hostname: page-component-cd4964975-g4d8c Total loading time: 0 Render date: 2023-03-27T18:21:46.788Z Has data issue: true Feature Flags: { "useRatesEcommerce": false } hasContentIssue true

Risk Factors Associated with Permanent Access-Site Infections in Chronic Hemodialysis Patients

Published online by Cambridge University Press:  02 January 2015

Robert A. Bonomo*
Division of Geriatrics, University Hospitals of Cleveland, Cleveland, Ohio
Dora Rice
The Division of Infectious Diseases, Veterans' Affairs Medical Center, Cleveland, Ohio
Christopher Whalen
General Internal Medicine, Veterans' Affairs Medical Center, Cleveland, Ohio The Department of Epidemiology and Biostatistics, Case Western Reserve School of Medicine, Cleveland, Ohio
David Linn
Nephrology, Veterans' Affairs Medical Center, Cleveland, Ohio
Elizabeth Eckstein
The Division of Infectious Diseases, Veterans' Affairs Medical Center, Cleveland, Ohio
David M. Shlaes
The Division of Infectious Diseases, Veterans' Affairs Medical Center, Cleveland, Ohio
Fairhill Institute for the Elderly, 12200 Fairhill Rd, Cleveland, OH 44120



To determine the epidemiological risk factors associated with permanent access-site (PAS) infection in a population of chronic hemodialysis patients.


Retrospective cohort analysis.


Hemodialysis unit of a 400-bed Department of Veterans' Affairs hospital.


A cohort of 94 males (1,316 patient months) was studied. Fifty-one PAS infections in 31 patients were observed. SiX patients had two PAS infections, four patients had three infections, and two patients had four infections. Twenty-nine of the 31 patients with PAS infections were bacteremic at least once. Univariate analysis identified seven factors significantly associated with PAS infection in this population: location of PAS other than forearm, type of vascular access (poletrafluoroethylene [PTFE] versus endogenous arteriovenous [AV] fistula), limited ambulatory status, residence in a nursing home, bacterial infection at a distant site, number of access-site revisions, and number of hospitalizations. In a logistic regression analysis, only graft type and number of PTFE graft revisions were associated independently with PAS infection. The odds ratio for PAS infection in PTFE grafts compared to endogenous AV fistula was 7.8; the odds ratio for PAS infection with each PTFE graft revision was 1.5.


PAS infections were associated independently with the type of graft and the number of PTFE graft surgical revisions.

Original Articles
Copyright © The Society for Healthcare Epidemiology of America 1997

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)


1.Tellis, VA, Kohlberg, WI, Bhat, DJ, Driscoll, B, Veith FI Expanded polytetrafluorethylene graft fistula for chronic hemodialysis. Ann Surg 1979;189:101105.Google Scholar
2.Burdick, JF, Scott, W, Cosimi, AB. Experience with DacronR graft arteriovenous fistulas for dialysis access. Ann Surg 1978;187:262266.Google Scholar
3.Kheriakian, GM, Roedersheimer, RL, Arbaugh, JJ, Newmark, KJ, King, R. Comparison of autogenous fistula versus expanded polytetrafluoroethylene graft fistula for angioaccess in hemodialysis. Am J Surg 1986;152:238243.Google Scholar
4.Winsett, OE, Wolma, FJ. Complications of vascular access for hemodialysis. South J Med 1985;78:513517.Google Scholar
5.Toridor, JHM, Herman, JMMPH, Kwan, TS, Diderich, PM. Long-term follow-up of the polytetrafluoroethylene (PTFE) prothesis as an arteriovenous fistula for hemodialysis. Eur J Vase Surg 1988;2:36.Google Scholar
6.Munda, R, First, MR, Alexander, JW, Linnemann, CC, Fidler, JP, Kittur, D. Polytetrafluoroethylene graft survival in hemodialysis JAMA 1983;249:219222.Google Scholar
7.Zibari, GB, Rohr, MS, Landreneau, MD, et al.Complications of permanent hemodialysis vascular access. Surgery 1988;104:681686.Google Scholar
8.Padberg, FT, Lee, FT, Curl, GRHemoaccess site infection. Surg Gynecol Obstet 1992;174:103108.Google Scholar
9.Morgan, AP, Knight, DC, Tilney, NL. Femoral triangle sepsis in dialysis patients. Ann Surg 1980;191:460464.Google Scholar
10.Kessler, M, Hoeri, B, Mayeux, D, Hestin, D, Fontenaille, C. Bacteremia in patients on chronic hemodialysis: a multicenter prospective survey. Nephron 1993;64:95100.Google Scholar
11.Murray, PR, ed. Mannual of Clinical Microbiology. 6th ed. Washington, DC: ASM Press; 1995.Google Scholar
12.National Committee for Clinical Laboratory Standards 1993. Approved Standards M2-A5 Peformance Standards for Antimicrobial Disc Susceptibility Tests. 5th ed. Villanova, PANCCLS; 1993.Google Scholar
13.Rothman, KJ. Modern Epidemiology. Boston, MA: Little, Brown and Co; 1986.Google Scholar
14.Hosmer, DW, Lemeshow, S. Applied Logistic Regression. New York City, NY: Wiley; 1989.Google Scholar
15.Goldman, M, Vanherweghem, JL. Bacterial infections in chronic hemodialysis patients: epidemiologic and pathophysiologic aspects. Adv Nephrol Necker Hosp 1990;19:315332.Google Scholar
16.Port, FK. Mortality and causes of death in patients with end stage renal failure. Am J Kidney Dis 1990;15:215217.Google Scholar
17.Nsouli, DA, Lazarus, JM, Schoenbaum, SC, Gotlieb, MN, Lowrie, EG, Shocair, M. Bacteremic infection in hemodialysis. Arch Intern Med 1979;139:12551258.Google Scholar
18.Higgins, RM. Infections in a renal unit. Q J Med 1989;70:4151.Google Scholar
19.Boelaert, JR, Daneels, RF, Schurgers, ML, Matthys, EG, Gordts, BZ, Van Landuyt, HW. Iron overload in haemodialysis patients increases the risk of bacteremia. A prospective study. Nephrol Dial Transplant 1990;5:130134Google Scholar